In an industry where speed and precision can directly affect patient outcomes, pharma companies are under pressure to ...
Success with a smart VF is less about the screens and more about how people interact with the data and each other.
Pharma’s finally catching up: real-time data is helping teams move faster, stay compliant and deliver better care where it ...
However, if pharma manufacturers aren’t using RWD in a strategic way, they’ll miss out on its full potential. And with that, they risk costly inefficiencies, slowing down their time to bring therapies ...
BERLIN--(BUSINESS WIRE)--Regulatory News: TME Pharma N.V. (Euronext Growth Paris: ALTME), a biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor ...
POTOMAC, Md.--(BUSINESS WIRE)--IGC Pharma, Inc. (NYSE American: IGC) ("IGC Pharma" or the "Company") today announced data that reinforces the therapeutic potential of IGC-AD1 as a disease-modifying ...
Tonix Pharmaceuticals (TNXP) presented data on Tonmya, which was investigated as TNX-102 SL, at the 2025 American College of Rheumatology ...
New findings highlight Telomir-1’s impact on CASP8 and GSTP1, two critical genes that regulate cell death and glutathione-based detoxification pathways often disrupted in cancer. MIAMI, FLORIDA / ...
For years, MASH was where drug development dreams went to die. | After Rezdiffra’s approval and Wegovy’s label expansion, ...
Terns Pharmaceuticals' trial data from its oral GLP-1 treatment for obesity missed a high threshold for efficacy, safety and tolerability. The biopharmaceutical company said Tuesday it will not ...
Mistargeted and irrelevant ads plague the TV viewing experience. Pharma brands struggle with targeting and measurement because patient data is highly regulated. A web of national laws, namely HIPAA, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results